Page 2 - Privo Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Privo Technologies, Inc. ("Privo"), a biopharmaceutical company focused on optimizing state-of-the-art chemotherapies to be "Tough on cancer, Easy on patients", announced today a poster presentation on the safety and efficacy of PRV111 in patients with early-stage Head and Neck Squamous Cell Carcinoma (HNSCC). PRV111 is an anticancer topical patch that allows for locoregional treatment.

PRV111 Patch Topical cancer treatment developed by Privo Technologies PEABODY, Mass. - June 3, 2021 - (Newswire.com) Privo Technologies, Inc. ("Privo"), a biopharmaceutical company focused on optimizing state-of-the-art chemotherapies to be "Tough on cancer, Easy on patients", ann...

Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced Share Article ROCKVILLE, Md. (PRWEB) February 22, 2021 Privo Technologies and its chief executive officer, Manijeh Goldberg, Ph.D., have been selected as the winner of the AIM-HI Accelerator Fund’s inaugural Women’s Venture Competition, a first of its kind program for female entrepreneurs starting oncology companies. Privo Technologies has developed a nano-engineered platform for redesigning the mechanism of action of potent cancer me...

David Perry It was a cousin’s lacrosse injury that inspired Alyssa Mulry to dream up ConnectKnee, a brace that tracks a patient’s recovery time. Mulry’s cousin dislocated her patella during a soccer game, requiring long recovery. Then a friend and family members also suffered knee injuries. “I saw first-hand how limited and discouraging recovery for a knee injury was,” says Mulry, a senior biomedical engineering major from Rutland, Massachusetts. “One thing stayed the same: a slow and often discouraging recovery. Then the idea really just took off after that.â€...